August 17, 2023 Comments Off on New patent for Gilead Sciences drug EPCLUSA Posted in: Patent Added Annual Drug Patent Expirations for EPCLUSA Epclusa is a drug marketed by Gilead Sciences Inc and is included in two NDAs. It is available from two suppliers. There are fifteen…
The post New patent for Gilead Sciences drug EPCLUSA appeared first on Drug…
August 17, 2023 Comments Off on New patent for United Therap drug TYVASO Posted in: Patent Added Annual Drug Patent Expirations for TYVASO Tyvaso is a drug marketed by United Therap and is included in two NDAs. It is available from one supplier. There are nine patents…
The post New patent for United Therap drug TYVASO appeared first on DrugPatentW…
